GlassScriptPhysician profile
Evan J Ward
NPI 1841616679
$1,746.88
in general payments reported to CMS, 2019-2025
15 companies · $662 in 2025
The $662 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $268 · 2022: $241 · 2023: $240 · 2024: $336 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913 · Travel and Lodging: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.55 |
| Travel and Lodging | $325.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $817.86 | 2022-2025 | Q-Fix, Acufex, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $487.34 | 2021-2024 | Mako |
| Medinc of Texas | $95.51 | 2022-2023 | |
| Bioventus LLC | $80.16 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Painteq LLC | $60.59 | 2024 | Painteq |
| Vertex Pharmaceuticals Incorporated | $27.53 | 2025 | |
| Sanofi-Aventis U.S. LLC | $26.92 | 2022 | |
| Abbvie INC. | $26.35 | 2023 | |
| Biomarin Pharmaceutical INC. | $24.87 | 2022 | |
| International Rehabilitative Sciences, INC | $23.70 | 2023 | Rs 4i Plus Sequential Stimulator |
| Amgen INC. | $17.58 | 2025 | Krystexxa |
| Innovation Technologies INC | $16.24 | 2023 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $15.63 | 2025 | Zilretta, Iovera |
| Abbott Laboratories | $15.21 | 2022 | |
| Alafair Biosciences, INC. | $11.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.